Effects Of Percutaneous Transcatheter Arterial Chemoembolization On The Treatment Of Liver Cancer And Its Function

Objective: The purpose of this study was to determine the prothrombin time in the peripheral blood of 37 patients undergoing transcatheter arterial chemoembolization before operation,three days after operation,and one month after operation.PT,TBIL,ALB,Che,ALT,AST,and Child-Pugh grade scores were statistically analyzed to evaluate the effect of TACE treatment on liver function.The changes in tumor imaging size were evaluated by m RECIST criteria to analyze the therapeutic effect of TACE.Data: From October 2016 to November 2018,a total of 37 patients in our hospital received at least one TACE treatment.This experiment was all patients with primary liver cancer and hepatitis B.TACE treatment experimental patients were divided into There were 16 people in group A(non-cirrhosis group)and 21 people in group B(cirrhosis group).Methods:Statistically significant data were performed by measuring the preoperative and postoperative AST,ALT,Che,PT,ALB,and TBI,ChildPugh grading scores,the degree of liver cirrhosis,and the effects of TACE treatment in groups A and B.In the analysis,the differences were statistically significant at P<0.05.Finally,the m RECIST evaluation criteria for solid tumors were used to evaluate the tumor treatment effect.Results: The changes of liver injury and liver function indicators over time between the two groups did not vary with the grouping(P > 0.05);the liver injury and liver function indicators between the two groups did not differ statistically at different periods(P > 0.05).The three-day Child-Pugh classification of group A was higher than the preoperative score,and was statistically significant(P <0.05);there was no difference between the Child-Pugh classification of group A one month after operation and the Group B child-pugh classification Statistical significance(P > 0.05);There was no significant relationship between the difference in Child-Pugh grading score between the two groups and whether they had liver cirrhosis(P > 0.05).The change in tumor size before and after surgery was statistically significant(P <0.05).The total tumor necrosis effective rate(CR + PR)was 18.9%,and the tumor control rate(DCR = CR + PR + SD)was 91.9%.Conclusion: TACE effectively controls the growth of liver cancer,and TACE has a poor ablation effect on tumors;the effect of TACE treatment on liver function can be restored to the preoperative level no matter whether it is combined with cirrhosis after one month;TACE treatment is still a minimally invasive treatment method.Causes a certain degree of liver damage and leads to a decline in liver function.